ID

23028

Beschrijving

NCT00340080 / VIIV-CNA106030 https://clinicaltrials.gov/ct2/show/NCT00340080 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Day 1 (Cohort Study) Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Link

https://clinicaltrials.gov/ct2/show/NCT00340080

Trefwoorden

Versies (1)
  1. 20-06-17 20-06-17 -
Geüploaded op

20 juni 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Genetic Screening For HLA-B*5701 n Patients with HIV Day 1 NCT00340080

Engels

Genetic Screening For HLA-B*5701 Day 1 NCT00340080

1 Formulieren  
Day 1
Beschrijving

Day 1

Alias
UMLS CUI-1
C1516637
UMLS CUI-2
C0009247
Subject Identifier
Beschrijving

Subject Identifier

Datatype

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Beschrijving

Visit Date

Datatype

date

Alias
UMLS CUI [1]
C1320303
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
Beschrijving

cohort sub-study

Datatype

text

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C0009247
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
Beschrijving

If Yes, record each medication on a separate line using Trade Names where possible.

Datatype

text

Alias
UMLS CUI [1]
C1963724
Drug Name (Trade name preferred)
Beschrijving

If Yes, record each medication on a separate line using Trade Names where possible.

Datatype

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C1963724
Start Date
Beschrijving

If Yes, record each medication on a separate line using Trade Names where possible.

Datatype

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1963724
Stop Date
Beschrijving

If Yes, record each medication on a separate line using Trade Names where possible.

Datatype

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1963724
Ongoing Medication?
Beschrijving

If Yes, record each medication on a separate line using Trade Names where possible.

Datatype

text

Alias
UMLS CUI [1,1]
C2826666
UMLS CUI [1,2]
C1963724
Vital signs: Blood pressure systolic
Beschrijving

Blood pressure systolic

Datatype

integer

Maateenheden
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Vital signs: Blood pressure diastolic
Beschrijving

Blood pressure diastolic

Datatype

integer

Maateenheden
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Vital signs: Heart rate
Beschrijving

Heart rate

Datatype

integer

Maateenheden
  • beats/minute
Alias
UMLS CUI [1]
C0018810
beats/minute
Vital signs: Temperature
Beschrijving

Temperature

Datatype

float

Maateenheden
  • °C
Alias
UMLS CUI [1]
C0005903
°C
Terug naar het begin van de pagina

Similar models

Genetic Screening For HLA-B*5701 Day 1 NCT00340080

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Day 1
C1516637 (UMLS CUI-1)
C0009247 (UMLS CUI-2)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
text
C1516637 (UMLS CUI [1,1])
C0009247 (UMLS CUI [1,2])
Eligibility Question
Code List
Is subject going to be followed prospectively in the cohort sub-study of HLA-B*5701 positive subjects?
CL Item
Yes (Y)
CL Item
No (N)
Item
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
text
C1963724 (UMLS CUI [1])
Eligibility Question
Code List
Has the subject previously received and permanently stopped antiretroviral therapy prior to Day 1?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name (Trade name preferred)
text
C2360065 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Eligibility Question
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)
Blood pressure systolic
Item
Vital signs: Blood pressure systolic
integer
C0871470 (UMLS CUI [1])
Blood pressure diastolic
Item
Vital signs: Blood pressure diastolic
integer
C0428883 (UMLS CUI [1])
Heart rate
Item
Vital signs: Heart rate
integer
C0018810 (UMLS CUI [1])
Temperature
Item
Vital signs: Temperature
float
C0005903 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial